Filing Flows › Novartis AG (NVS) › Q2 2026 › vs Q1 2026
Novartis AG (NVS) Q2 2026 vs Q1 2026 (quarter over quarter)
Novartis AG's revenue rose $1.3B (+10%) from $13.1B in Q1 2026 to $14.4B in Q2 2026. Operating margin 33.0% against 32.3% (+0.7 pts).
Novartis AG, Q2 2026: revenue $14.4B (+2% year over year), operating margin 33.0%, net earnings $3.3B, operating cash flow $5.9B. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 33.0% | 32.3% | +0.7 pts |
| Net margin | 22.6% | 24.1% | -1.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $14.4B | $13.1B | $1.3B | +10% |
| Operating profit | $4.8B | $4.2B | $515M | +12% |
| Costs & expenses | $9.7B | $8.9B | $780M | +9% |
| Pre-tax earnings | $3.3B | $3.2B | $101M | +3% |
| Other expense, net | $1.5B | $1.1B | $414M | +38% |
| Net earnings | $3.3B | $3.2B | $101M | +3% |
Questions
How much did Novartis AG's revenue grow quarter over quarter in Q2 2026?
Novartis AG's revenue rose $1.3B (+10%) from $13.1B in Q1 2026 to $14.4B in Q2 2026. Operating margin 33.0% against 32.3% (+0.7 pts).